Comments
Loading...

PAVmed Analyst Ratings

PAVMZNASDAQ
Logo brought to you by Benzinga Data
$0.00480
-0.00220-31.43%
After Hours: Feb 26, 8:47 AM EDT

PAVmed Analyst Ratings and Price Targets | NASDAQ:PAVMZ | Benzinga

PAVmed Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for PAVmed Corp from these most-recent analyst ratings.

Analyst Ratings for PAVmed

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for PAVmed (PAVMZ) stock?

A

There is no price target for PAVmed

Q

What is the most recent analyst rating for PAVmed (PAVMZ)?

A

There is no analyst for PAVmed

Q

When was the last upgrade for PAVmed (PAVMZ)?

A

There is no last upgrade for PAVmed

Q

When was the last downgrade for PAVmed (PAVMZ)?

A

There is no last downgrade for PAVmed.

Q

When is the next analyst rating going to be posted or updated for PAVmed (PAVMZ)?

A

There is no next analyst rating for PAVmed.

Q

Is the Analyst Rating PAVmed (PAVMZ) correct?

A

There is no next analyst rating for PAVmed.

Browse analyst ratings and price targets on all stocks.

People Also Watch